COXAPROL
COXAPROL
Authorised
- Amprolium hydrochloride
Product identification
Medicine name:
COXAPROL
Active substance:
- Amprolium hydrochloride
Target species:
-
Poultry
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Amprolium hydrochloride119.90/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Concentrate for oral solution
Withdrawal period by route of administration:
-
Oral use
-
Poultry
-
Meat and offal0day
-
Eggs0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP51AX09
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Available in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Huvepharma S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Huvepharma S.A.
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/6959048 5/2015
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 16/09/2024
fr-puar-600000040630-np-rpe187-fr.pdf
French (PDF)
Download Published on: 7/01/2026